-
公开(公告)号：EP2131859B1
公开(公告)日：2016-04-27
申请号：EP08718285.3
申请日：2008-03-27
申请人： Nestec S.A.
IPC分类号： A23C9/20 , A61K35/747 , A61P1/12 , A61P37/08
CPC分类号： A61K35/747 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/73 , A23Y2300/49 , A61K35/745 , A23V2200/3204 , A23V2200/3202 , A23V2200/304 , A23V2250/28
摘要： The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section.
-
公开(公告)号：EP1638418B1
公开(公告)日：2012-08-29
申请号：EP04739936.5
申请日：2004-06-16
申请人： Nestec S.A.
CPC分类号： A61K31/198 , A23K20/142 , A23K20/147 , A23K50/40 , A23L33/175 , A23L33/40 , A23V2002/00 , A61K9/0095 , A61K31/195 , A61K31/401 , A23V2250/0642 , A23V2250/064 , A23V2250/0648 , A23V2250/0616 , A23V2250/0612 , A23V2250/16 , A23V2250/1578 , A23V2250/161 , A23V2250/1612 , A23V2250/1592 , A23V2250/1588 , A23V2250/1642 , A23V2250/06 , A23V2250/156 , A23V2250/702 , A23V2250/704 , A23V2250/641 , A23V2250/0644
摘要： The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favour the growth of bacteria favourable to indivuduals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
-
公开(公告)号：EP2373182A1
公开(公告)日：2011-10-12
申请号：EP09756496.7
申请日：2009-11-23
申请人： Nestec S.A.
发明人： DARMAUN, Dominique , FICHOT, Marie-Claire , PILOQUET, Hugues , ROCHAT, Florence , ROUGE, Carole , ROZE, Jean-Christophe
CPC分类号： A61K35/744 , A23L33/135 , A23L33/30 , A23L33/40 , A23V2002/00 , A61K35/747 , A23V2200/3204 , A23V2250/1882 , A23V2250/156 , A23V2250/70 , A23V2250/0612 , A23V2250/0644
摘要： The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in low birth weight infants. The invention is also concerned with the use of specific probiotics in the manufacture of low-birth weight infant formulations.
-
4.发明公开PROBIOTICS TO REDUCE EPISODES OF DIARRHOEA IN INFANTS BORN BY CAESAREAN SECTION 审中-公开益生菌所生BY KAISER CUT婴幼儿腹泻的约化
公开(公告)号：EP2129393A1
公开(公告)日：2009-12-09
申请号：EP08718272.1
申请日：2008-03-27
申请人： Nestec S.A.
IPC分类号： A61K39/05
CPC分类号： A61K35/747 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/73 , A23Y2300/49 , A61K35/745 , A23V2200/3204 , A23V2200/3202 , A23V2200/304 , A23V2250/28
摘要： The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section.
-
5.发明公开PROBIOTICS TO REDUCE DEVELOPMENT OF ALLERGY IN INFANTS BORN BY CAESAREAN SECTION 审中-公开益生菌来降低过敏的发展 - 以KAISER CUT出生的婴儿
公开(公告)号：EP2129242A1
公开(公告)日：2009-12-09
申请号：EP08718275.4
申请日：2008-03-27
申请人： Nestec S.A.
CPC分类号： A61K35/747 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/73 , A23Y2300/49 , A61K35/745 , A23V2200/3204 , A23V2200/3202 , A23V2200/304 , A23V2250/28
摘要： The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section.
-
公开(公告)号：EP3344269A1
公开(公告)日：2018-07-11
申请号：EP16759752.5
申请日：2016-08-31
申请人： Nestec S.A.
发明人： ROCHAT, Florence , BERGONZELLI DEGONDA, Gabriela , HAUSER, Jonas , SCHMITT, Jeroen Antonius Johannes , ALVES NUNES, Tiago , MARQUARDT, Valerie
IPC分类号： A61K35/745 , A61P25/24
CPC分类号： A61K35/745
摘要： B. longum ATCC BAA-999, or a composition comprising B. longum ATCC BAA-999, for use in an individual to; support breastfeeding initiation and/or to optimise breastfeeding duration and/or to optimize the quality and/or quantity ofbreast milk and/or to prevent or treat peripartum emotional distress and/or to regulate amygdala activity and/or to regulate the release of CRH, and to prevent or treat the negative effects of peripartum emotional distress in the offspring of individuals.
-
7.发明授权NUTRITIONAL COMPOSITION FOR PROMOTING GUT MICROBIOTA BALANCE AND HEALTH 有权NAHRUNGSMITTELFÜRDIE VERBESSERUNG DER GESUNDHEIT UND DER DARMFLORA
公开(公告)号：EP2498626B1
公开(公告)日：2015-06-17
申请号：EP10779417.4
申请日：2010-11-11
申请人： Nestec S.A.
发明人： ROUGHEAD, Zamzam (Fariba) , BENYACOUB, Jalil , ROESSLE, Claudia , MAGER, Jennifer Rae , SWANSON, Julie Ann , GREENBERG, Norman Alan , BOLSTER, Douglas Richard , GARCIA RODENAS, Clara Lucia , ROCHAT, Florence
CPC分类号： A23L33/21 , A23L29/244 , A23L29/25 , A23L33/10 , A23L33/40 , A23V2002/00 , A61K31/702 , A61K31/715 , A61K38/28 , A23V2200/324 , A23V2200/306 , A23V2250/5062 , A23V2250/503 , A23V2250/28
摘要： The present disclosure relates to nutritional compositions comprising a fructo-oligosaccharide (FOS) in an amount of 35 to 44% by weight; a polysaccharide that is not a partially hydrolyzed guar gum such as, for example, an arabinogalactan in an amount of 50% to 38% by weight; and inulin in an amount of 12% to 24% by weight. The FOS and the polysaccharide may be present in a weight ratio of about 1:1. More specifically, the FOS and inulin may be present in a weight ratio of about 7:3. Also provided are methods of promoting gut microbiota balance and health. The methods include administering an effective amount of the nutritional composition to patients in need of same.
摘要翻译： 本公开涉及包含35至44重量％的低聚果糖（FOS）的营养组合物; 不是部分水解的瓜尔胶的多糖，例如50-38重量％的阿拉伯半乳聚糖; 和菊糖，其量为12重量％至24重量％。 FOS和多糖可以以约1:1的重量比存在。 更具体地说，FOS和菊粉可以以约7:3的重量比存在。 还提供了促进肠道微生物平衡和健康的方法。 所述方法包括向有需要的患者施用有效量的营养组合物。
-
公开(公告)号：EP2131680B1
公开(公告)日：2013-08-14
申请号：EP08735504.6
申请日：2008-03-27
申请人： Nestec S.A.
CPC分类号： A61K35/747 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/73 , A23Y2300/49 , A61K35/745 , A23V2200/3204 , A23V2200/3202 , A23V2200/304 , A23V2250/28
摘要： The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section.
-
9.发明公开PROBIOTICS FOR USE IN EXPECTING FEMALE MAMMALS FOR ENHANCING THE IMMUNITY OF THEIR OFFSPRINGS 有权FOR USE IN怀孕的女性益生菌哺乳动物，以提高他们的后代免疫力
公开(公告)号：EP2348890A1
公开(公告)日：2011-08-03
申请号：EP09724569.0
申请日：2009-03-11
申请人： Nestec S.A.
CPC分类号： A23L33/135 , A23L33/21 , A23V2002/00 , A23V2200/30 , A23Y2220/73 , A61K9/0053 , A61K35/741 , A61K35/745 , A61K35/747 , A61K39/09 , A61K2035/115
摘要： The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of offspring against infectious diseases.
摘要翻译： 本发明涉及一种在怀孕的雌性哺乳动物，以提高后代的免疫状态使用益生菌。 使用可诱导到出生后的后代的增强响应于对传染性抗原的曝光。 最终，在期待女性使用益生菌可诱导针对传染病更好的保护后代。
-
10.发明公开PROBIOTICS TO INCREASE IGA SECRETION IN INFANTS BORN BY CAESAREAN SECTION 有权益生菌来改善IGA分泌由KAISER CUT INFANTS
公开(公告)号：EP2315595A1
公开(公告)日：2011-05-04
申请号：EP09800034.2
申请日：2009-07-15
申请人： Nestec S.A.
CPC分类号： A23L1/30 , A23L33/10 , A23L33/135 , A23L33/40 , A23V2002/00 , A61K35/745 , A61K35/747 , A23V2200/3204 , A23V2250/1578 , A23V2250/16 , A23V2250/161 , A23V2250/1612 , A23V2250/1614 , A23V2250/1618 , A23V2250/1626 , A23V2250/1872 , A23V2250/1874 , A23V2250/702 , A23V2250/704 , A23V2250/708 , A23V2250/712 , A23V2250/7142
摘要： Use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for increasing IgA secretion in an infant delivered by caesarean section during the first four months of the life of the infant.
-
-
-
-
-
-
-
-
-
搜索结果
25 条记录 (耗时 0.017 秒)
